White Paper

Detecting Neurobehavioral Effects

Battelle's white paper will help you understand how neurobehavioral toxicology testing provides the critical insights you need to make informed decisions to help you reach your end goal. But where do you begin—and who can you trust to deliver appropriately standardized tests?
Get the white paper

What's Inside

Does a potential new blood pressure drug have negative effects on the nervous system? Which therapies show the most promise for treatment of Alzheimer’s disease? Are growing rates of neuropsychiatric disorders, such as Attention Deficit Hyperactivity Disorder (ADHD) and autism, linked to chemical exposure? How can we protect soldiers and civilians who are at risk from exposure to chemical weapons?

Neurobehavioral testing aims to answer these and other important questions. But all testing preclinical CROs are not created equal. This white paper will help you choose the right partner for your specific neuro-tox challenge. 


Explore the 4 primary industries that should consider neurobehavioral testing, and how they benefit.

Testing Tiers

Discover the difference between the 3 tiers of neurobehavioral testing & what you should know about each.

Critical Considerations

This white paper outlines the 6 critical considerations that organizations should keep in mind when selecting a preclinical CRO for testing.

Our Solutions

Discover our neurobehavioral testing solutions here at Battelle.